ATC code S03 Ophthalmological and otological preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup S03 is part of the anatomical group S Sensory organs.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QS03.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
S03A Anti-infectives
editS03AA Anti-infectives
edit- S03AA01 Neomycin
- S03AA02 Tetracycline
- S03AA03 Polymyxin B
- S03AA04 Chlorhexidine
- S03AA05 Hexamidine
- S03AA06 Gentamicin
- S03AA07 Ciprofloxacin
- S03AA08 Chloramphenicol
- S03AA30 Antiinfectives, combinations
S03B Corticosteroids
editS03BA Corticosteroids
edit- S03BA01 Dexamethasone
- S03BA02 Prednisolone
- S03BA03 Betamethasone
S03C Corticosteroids and anti-infectives in combination
editS03CA Corticosteroids and anti-infectives in combination
edit- S03CA01 Dexamethasone and antiinfectives
- S03CA02 Prednisolone and antiinfectives
- S03CA04 Hydrocortisone and antiinfectives
- S03CA05 Fludrocortisone and antiinfectives
- S03CA06 Betamethasone and antiinfectives
- S03CA07 Methylprednisolone and antiinfectives
S03D Other ophthalmological and otological preparations
edit- Empty group
References
edit- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code S03". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QS03". WHO Collaborating Centre for Drug Statistics Methodology.